{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T05:50:31Z","timestamp":1774158631594,"version":"3.50.1"},"reference-count":35,"publisher":"American Society for Microbiology","issue":"12","content-domain":{"domain":["asm.org"],"crossmark-restriction":true},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Influenza A(H7N9) virus pneumonia is associated with a high case fatality rate in humans. Multiple viral factors have been postulated to account for the high virulence of the virus. It has been reported that patients with influenza A(H7N9) virus infection have relatively low titers of neutralizing antibodies compared to those with seasonal influenza virus infections. In this study, we compared serum hemagglutination inhibition (HI) and microneutralization (MN) antibody titers of mice challenged with wild-type A(H7N9) viruses [H7N9(Anhui) and H7N9(Zhejiang)], an A(H1N1)pdm09 virus [pH1N1(2009)], and a recombinant A(H7N9) virus with PR8\/H1N1 internal genes (rg-PR8-H7-N9). All mice infected by H7N9(Anhui) and H7N9(Zhejiang) developed serum HI antibodies at 14 days postinfection (dpi) but no detectable MN antibodies, even at 28 dpi. A low level of neutralizing activity was detected in H7N9(Anhui)- and H7N9(Zhejiang)-infected mice using fluorescent focus MN assay, but convalescent-phase serum samples obtained from H7N9(Anhui)-infected mice did not reduce the mortality of naive mice after homologous virus challenge. Reinfection with homologous A(H7N9) virus induced higher HI and MN titers than first infection. In contrast, pH1N1(2009) virus infection induced robust HI and MN antibody responses, even during the first infection. Moreover, rg-PR8-H7-N9 induced significantly higher HI and MN antibody titers than H7N9(Zhejiang). In conclusion, the internal genes of A(H7N9) virus can affect the humoral immune response against homologous viral surface proteins, which may also contribute to the virulence of A(H7N9) virus.<\/jats:p>","DOI":"10.1128\/cvi.00443-15","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T02:18:59Z","timestamp":1444270739000},"page":"1235-1243","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":15,"title":["Suboptimal Humoral Immune Response against Influenza A(H7N9) Virus Is Related to Its Internal Genes"],"prefix":"10.1128","volume":"22","author":[{"given":"Andrew C. Y.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houshun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna J. X.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuangen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan F. N.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelvin K. W.","family":"To","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwok-Yung","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","published-online":{"date-parts":[[2015,10,7]]},"reference":[{"key":"key20180919073817_B1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/MCP.0000000000000047","article-title":"Viral lung infections: epidemiology, virology, clinical features, and management of avian influenza A(H7N9)","volume":"20","year":"2014","journal-title":"Curr Opin Pulm Med"},{"key":"key20180919073817_B2","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/cid\/cit541","article-title":"Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus","volume":"57","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key20180919073817_B3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S1473-3099(13)70167-1","article-title":"The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities","volume":"13","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key20180919073817_B4","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/S0140-6736(13)60903-4","article-title":"Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome","volume":"381","year":"2013","journal-title":"Lancet"},{"key":"key20180919073817_B5","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1038\/emi.2012.24","article-title":"Avian influenza A H5N1 virus: a continuous threat to humans","volume":"1","year":"2012","journal-title":"Emerg Microbes Infect"},{"key":"key20180919073817_B6","article-title":"Influenza at the human-animal interface","volume-title":"Summary and assessment as of 17 July 2015","author":"World Health Organization","year":"2015"},{"key":"key20180919073817_B7","doi-asserted-by":"publisher","first-page":"10556","DOI":"10.1128\/JVI.00570-14","article-title":"H7N9 and other pathogenic avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influenza virus and is associated with lethal outcome in mice","volume":"88","year":"2014","journal-title":"J Virol"},{"key":"key20180919073817_B8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nature12392","article-title":"Characterization of H7N9 influenza A viruses isolated from humans","volume":"501","year":"2013","journal-title":"Nature"},{"key":"key20180919073817_B9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/JVI.02390-14","article-title":"Assessment of the internal genes of influenza A (H7N9) virus contributing to high pathogenicity in mice","volume":"89","year":"2015","journal-title":"J Virol"},{"key":"key20180919073817_B10","doi-asserted-by":"publisher","first-page":"950","DOI":"10.4161\/hv.24939","article-title":"Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design","volume":"9","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"key20180919073817_B11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.4161\/hv.28135","article-title":"Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design","volume":"10","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"key20180919073817_B12","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","year":"2013","journal-title":"N Engl J Med"},{"key":"key20180919073817_B13","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1258\/ebm.2010.010071","article-title":"D225G mutation in hemagglutinin of pandemic influenza H1N1 (2009) virus enhances virulence in mice","volume":"235","year":"2010","journal-title":"Exp Biol Med (Maywood)"},{"key":"key20180919073817_B14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00705-014-2314-x","article-title":"Recombinant influenza A virus hemagglutinin HA2 subunit protects mice against influenza A(H7N9) virus infection","volume":"160","year":"2015","journal-title":"Arch Virol"},{"key":"key20180919073817_B15","doi-asserted-by":"publisher","first-page":"5509","DOI":"10.1038\/ncomms6509","article-title":"The K526R substitution in viral protein PB2 enhances the effects of E627K on influenza virus replication","volume":"5","year":"2014","journal-title":"Nat Commun"},{"key":"key20180919073817_B16","doi-asserted-by":"publisher","first-page":"e107966","DOI":"10.1371\/journal.pone.0107966","article-title":"Avian influenza A H7N9 virus induces severe pneumonia in mice without prior adaptation and responds to a combination of zanamivir and COX-2 inhibitor","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"key20180919073817_B17","doi-asserted-by":"publisher","first-page":"e41501","DOI":"10.1371\/journal.pone.0041501","article-title":"Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"key20180919073817_B18","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1128\/CVI.00555-10","article-title":"Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza","volume":"18","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"key20180919073817_B19","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3201\/eid2002.131094","article-title":"Human antibody responses to avian influenza A(H7N9) virus, 2013","volume":"20","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key20180919073817_B20","doi-asserted-by":"publisher","first-page":"e10864","DOI":"10.1371\/journal.pone.0010864","article-title":"Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus","volume":"5","year":"2010","journal-title":"PLoS One"},{"key":"key20180919073817_B21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/1743-422X-10-253","article-title":"The mouse and ferret models for studying the novel avian-origin human influenza A (H7N9) virus","volume":"10","year":"2013","journal-title":"Virol J"},{"key":"key20180919073817_B22","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1128\/JVI.01920-08","article-title":"Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza","volume":"83","year":"2009","journal-title":"J Virol"},{"key":"key20180919073817_B23","doi-asserted-by":"publisher","first-page":"6194","DOI":"10.1016\/j.vaccine.2013.10.061","article-title":"Phase I\/II trial of a replication-deficient trivalent influenza virus vaccine lacking NS1","volume":"31","year":"2013","journal-title":"Vaccine"},{"key":"key20180919073817_B24","first-page":"177","article-title":"Attenuated influenza virus vaccines with modified NS1 proteins","volume":"333","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"key20180919073817_B25","first-page":"73","article-title":"The NS1 protein: a multitasking virulence factor","volume":"386","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"key20180919073817_B26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/cid\/ciq106","article-title":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection","volume":"52","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key20180919073817_B27","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1378\/chest.12-2907","article-title":"Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection","volume":"144","year":"2013","journal-title":"Chest"},{"key":"key20180919073817_B28","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.vaccine.2015.03.009","article-title":"Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets","volume":"33","year":"2015","journal-title":"Vaccine"},{"key":"key20180919073817_B29","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1016\/j.vaccine.2013.07.043","article-title":"Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A\/Anhui\/1\/2013 (H7N9) protection and heterologous A\/chicken\/Jalisco\/CPA1\/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus","volume":"31","year":"2013","journal-title":"Vaccine"},{"key":"key20180919073817_B30","first-page":"234ra255","article-title":"A cell culture-derived MF59-adjuvanted pandemic A\/H7N9 vaccine is immunogenic in adults","volume":"6","year":"2014","journal-title":"Sci Transl Med"},{"key":"key20180919073817_B31","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1056\/NEJMc1313186","article-title":"A recombinant viruslike particle influenza A (H7N9) vaccine","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"key":"key20180919073817_B32","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1001\/jama.2014.12854","article-title":"Serological responses to an avian influenza A\/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial","volume":"312","author":"DMID 13-0032 H7N9 Vaccine Study Group","year":"2014","journal-title":"JAMA"},{"key":"key20180919073817_B33","doi-asserted-by":"publisher","first-page":"e0120793","DOI":"10.1371\/journal.pone.0120793","article-title":"Evaluation of MDCK cell-derived influenza H7N9 vaccine candidates in ferrets","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"key20180919073817_B34","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1128\/CVI.00816-13","article-title":"Toll-like receptor 7 agonist imiquimod in combination with influenza vaccine expedites and augments humoral immune responses against influenza A(H1N1)pdm09 virus infection in BALB\/c mice","volume":"21","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"key20180919073817_B35","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1093\/cid\/ciu582","article-title":"Immunogenicity of intradermal trivalent influenza vaccine with topical imiquimod: a double blind randomized controlled trial","volume":"59","year":"2014","journal-title":"Clin Infect Dis"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.00443-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T15:59:29Z","timestamp":1589385569000},"score":1,"resource":{"primary":{"URL":"https:\/\/cvi.asm.org\/content\/22\/12\/1235"}},"subtitle":[],"editor":[{"given":"D. L.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,7]]},"references-count":35,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,11,24]]},"published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1128\/CVI.00443-15"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00443-15","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,7]]}}}